Targeting PAK etk...
Zhou
Guo-Lei
GL
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Field
Jeffrey
J
D016475:3T3 Cells; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D011905:Genes, ras / Q000187:drug effects; D006801:Humans; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020032:Tyrphostins / Q000494:pharmacology*; D054462:p21-Activated Kinases; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism
C081020:AG-879; D004791:Enzyme Inhibitors; D020032:Tyrphostins; C492367:BMX protein, human; C492366:Bmx protein, mouse; D011505:Protein-Tyrosine Kinases; C515903:PAK1 protein, human; C515905:Pak1 protein, mouse; D017346:Protein Serine-Threonine Kinases; D054462:p21-Activated Kinases; D018631:ras Proteins